Comprehensive Management of High Risk Cardiovascular Patients
Published on 19. April 2016
770 pages
978-1-040-17484-5 (ISBN)
Description
Filling a large gap in the literature, this book focuses on the management of patients who have, or are at risk of developing, cardiovascular disease. Designed to serve as a resource for the busy, practicing clinician, the approach is evidence-based but practical. Conceptual development and the exploration of biochemical and physiological mechanism
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
Professional and scholarly
File size
14,59 MB
ISBN-13
978-1-040-17484-5 (9781040174845)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Antonio M. Gotto | Peter P. Toth
Comprehensive Management of High Risk Cardiovascular Patients
Book
07/2007
1st Edition
CRC Press
€101.82
Article not available at the moment
Antonio M. Gotto | Peter P. Toth
Comprehensive Management of High Risk Cardiovascular Patients
Book
10/2006
1st Edition
CRC Press
€148.56
Shipment within 15-20 days
Persons
Gotto, Antonio M.; Toth, Peter P.
Content
Risk Factors for Cardiovascular Disease and the Framingham Study Equation, Arterial Hypertension, Obesity and Lifestyle Modification, Effects of Nutrient Supplements and Nutraceuticals on Risk for Cardiovascular Disease, Type 1 Diabetes Mellitus, Type 2 Diabetes, Management of Elevated Low-Density Lipoprotein Cholesterol. High-Density Lipoprotein Cholesterol, Triglycerides and Risk for Atherosclerotic Disease, Safety of Dyslipidemic Agents, The Metabolic Syndrome: Identification and Management of the Patient at High Risk for Cardiovascular Disease, Inflammatory Mediators and C-Reactive Protein, Chronic Kidney Disease, Anticoagulation and Antiplatelet Agents, Congestive Heart Failure: Epidemiology, Pathophysiology, and Current Therapies, Stroke Prevention, Peripheral Arterial Disease, Acute Myocardial Infarction, Tobacco and Cardiovascular Disease, Women and Coronary Heart Disease, Cardiovascular Disease in Racial and Ethnic Minorities
